The Cass Review has reshaped conversation around gender-affirming care in the NHS, yet questions remain about the evidence foundation on which its conclusions rest. This piece examines the review's methodology, the assumptions embedded within it, and the real-world impact of its recommendations on young people and their families.
Understanding what the review did well, where its scope was limited, and how its findings are being interpreted in clinical practice matters deeply to anyone involved in gender-affirming healthcare. Rather than accepting the review as a final word, there is value in looking again at the evidence, the gaps, and what comes next.